JPH05329192A - Infusion container - Google Patents
Infusion containerInfo
- Publication number
- JPH05329192A JPH05329192A JP4164121A JP16412192A JPH05329192A JP H05329192 A JPH05329192 A JP H05329192A JP 4164121 A JP4164121 A JP 4164121A JP 16412192 A JP16412192 A JP 16412192A JP H05329192 A JPH05329192 A JP H05329192A
- Authority
- JP
- Japan
- Prior art keywords
- container
- drug
- solution
- infusion
- communication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
(57)【要約】
【構成】 薬液取出口と、少なくとも2の薬剤容器との
連通口とを両端に有する変形自在なプラスチック製の溶
解液容器と、該溶解液容器の連通口側に該連通口を内包
した筒状支持部材と、該筒状支持部材に軸方向にスライ
ド自在に挿着され支持される連通手段および少なくとも
2の薬剤容器とからなる輸液容器であって、薬剤容器の
口のシール部および溶解液容器の連通口のシール部が連
通手段によって連通され、溶解液容器と薬剤容器が液体
連通するように構成された輸液容器である。
【効果】 2種以上の薬剤を液体に溶解させる際に、操
作が容易で手間がかからず、混合された薬液が漏れる虞
がなく、無菌的に薬剤と溶解液を混合することができ
る。また本発明輸液容器は部品点数が少なく安価に製品
を提供することができる。
(57) [Summary] [Structure] A deformable plastic solution container having a drug solution outlet and a communication port for at least two drug containers at both ends, and a communication port on the communication port side of the solution container. What is claimed is: 1. An infusion container comprising a tubular support member containing a mouth, a communication means axially slidably inserted in and supported by the tubular support member, and at least two drug containers. The infusion container is configured such that the seal portion and the seal portion of the communication port of the dissolution liquid container are communicated with each other by the communication means, and the dissolution liquid container and the medicine container are in fluid communication. [Effect] When dissolving two or more drugs in a liquid, the drug and the solution can be aseptically mixed without any trouble because the operation is easy and there is no risk of the mixed drug solution leaking. Further, the infusion container of the present invention has a small number of parts and can provide a product at low cost.
Description
【0001】[0001]
【産業上の利用分野】本発明は輸液容器に関する。さら
に詳しくは、粉末製剤や凍結乾燥製剤、固形製剤などの
乾燥薬剤と、その溶解液を分離した状態で保存してお
き、使用直前に容器内で溶解液と乾燥薬剤を無菌的に混
合し、液状の薬品として供給するための輸液容器に関す
る。FIELD OF THE INVENTION The present invention relates to an infusion container. More specifically, powder formulations, freeze-dried formulations, dry formulations such as solid formulations, and their dissolved solutions are stored in a separated state, and the dissolved solutions and the dried formulations are aseptically mixed in a container immediately before use, The present invention relates to an infusion container for supplying as a liquid medicine.
【0002】[0002]
【従来の技術】従来より病院などの医療機関において
は、バイアル等の薬剤容器に入った乾燥薬剤を蒸留水や
生食、ブドウ糖液などの溶解液(他の薬液を含む)に溶
解して点滴注射などに用いられている。このような場合
に簡便に使用できるように、乾燥薬剤を収容したバイア
ルを溶解液を収納した可撓性容器に直列状に連結してお
き、使用時に中空針の両端に穿刺部を有する穿刺針(両
頭針という)で両容器のゴム栓を穿刺してこれら二つの
容器を無菌的に連通するようにした輸液容器が提案され
ている。2. Description of the Related Art Conventionally, in medical institutions such as hospitals, a dry drug contained in a drug container such as a vial is dissolved in distilled water, a saline solution, a solution such as glucose solution (including other drug solutions), and then an intravenous injection is made. It is used for. In such a case, a vial containing a dry drug is connected in series to a flexible container containing a dissolution liquid so that it can be easily used, and a puncture needle having puncture parts at both ends of a hollow needle at the time of use. An infusion container has been proposed in which the rubber stoppers of both containers are punctured with a (double-ended needle) so that these two containers are aseptically connected.
【0003】特表昭61−501129号公報に示され
る輸液容器は、薬剤容器の収容されたカプセルと溶解液
の収容された可撓性容器とがチューブで接続されたもの
であり、チューブ内に設けられた連通手段によって薬剤
容器と可撓性容器が連通され、薬剤と溶解液とが無菌的
に混合されるようになっている。また、特開平2−12
27号公報に示される輸液容器は、薬剤容器の収容され
たカプセルをその結合部で溶解液容器の口部と接続し、
カプセルの結合部側に連通順序規制手段を備えた連通手
段を介在させたもので、連通手段により薬剤容器が刺通
されたのちに溶解液容器が刺通されて二つの容器が連通
され、薬剤と溶解液とが無菌的に混合されるようになっ
ている。また、実開昭63−135642号公報に示さ
れた輸液容器は、溶解液容器の口部のシール部に筒状の
適宜取外し可能なサポートリングを設け、このサポート
リングに上下スライド自在に両頭針を取り付けたもので
あり、両頭針を下方にスライドさせたときに、下部針体
が溶解液容器の口部のシール部に穿刺するようにしたも
のである。The infusion container disclosed in Japanese Patent Publication No. 61-501129 has a capsule containing a drug container and a flexible container containing a solution, which are connected by a tube. The medicine container and the flexible container are communicated with each other by the communication means provided so that the medicine and the solution are aseptically mixed. In addition, JP-A 2-12
The infusion container shown in Japanese Patent Publication No. 27 connects the capsule containing the drug container to the mouth of the dissolution liquid container at its joint,
A capsule is provided with a communication means provided with a communication sequence regulating means on the coupling part side of the capsule.After the medicine container is pierced by the communication means, the dissolution liquid container is pierced and the two containers are communicated with each other. And the lysate are mixed aseptically. Further, the infusion container disclosed in Japanese Utility Model Laid-Open No. 63-135642 is provided with a cylindrical removable support ring at the seal portion at the mouth of the dissolution liquid container, and the support ring is vertically slidable with a double-ended needle. Is attached, and when the double-ended needle is slid downward, the lower needle body punctures the seal portion at the mouth of the dissolution liquid container.
【0004】[0004]
【発明の解決しようとする課題】前記従来の輸液容器は
いずれも乾燥薬剤を収容した1つの薬剤容器と溶解液を
収容した1つの溶解液容器とを連通して乾燥薬剤と溶解
液とを無菌的に混合して薬液を形成し患者に点滴したも
のである。薬剤容器に収容する乾燥薬剤には2種以上の
薬剤を混合した混合薬剤も収容されているが、薬剤の組
み合わせによっては薬剤同志が反応して1つの薬剤容器
内に収容できない場合があるし、また薬剤の溶解液への
溶解度の差によって混合薬剤を同時に溶解液に溶解させ
るより個々の薬剤を順番に溶解液に溶解させる方がよい
場合がある。本発明の目的は2種以上の乾燥薬剤を1つ
の薬剤容器に混合して収容できない薬剤の組み合わせの
混合薬剤や2種以上の乾燥薬剤を混合して溶解液に溶解
させるより個々の薬剤を順番に溶解液に溶解させた方が
よい2種以上の薬剤を溶解液に溶解させるのに好適な輸
液容器を提供することにある。更に本発明の目的は操作
が容易で手間がかからず、混合された薬液が漏れる虞が
なく、部品点数の少ない、無菌的に薬剤と溶解液を混合
することのできる輸液容器を提供することである。In each of the conventional infusion solutions described above, one drug container containing a dry drug and one solution container containing a solution are communicated with each other to sterilize the dry drug and the solution. It is a drug solution that is mixed by mixing to form a drug solution, which is then instilled in a patient. The dry medicine to be contained in the medicine container also contains a mixed medicine in which two or more kinds of medicines are mixed, but depending on the combination of medicines, the medicines may react with each other and cannot be contained in one medicine container, In some cases, it may be better to sequentially dissolve the individual drugs in the dissolution liquid than to dissolve the mixed drugs in the dissolution liquid at the same time depending on the difference in solubility of the drugs in the dissolution liquid. An object of the present invention is to order individual drugs rather than a mixed drug having a combination of drugs that cannot contain two or more dry drugs in one drug container or a mixture of two or more dry drugs and dissolving them in a solution. Another object of the present invention is to provide an infusion container suitable for dissolving two or more kinds of drugs, which should be dissolved in a dissolving solution, in the dissolving solution. Further, an object of the present invention is to provide an infusion container which is easy to operate, hassle-free, has no possibility of leaking a mixed drug solution, has a small number of parts, and can aseptically mix a drug and a solution. Is.
【0005】[0005]
【課題を解決するための手段】すなわち、本発明は薬液
取出口と少なくとも2の薬剤容器との連通口とを両端に
有する押圧変形しうるプラスチック製の溶解液容器と、
該溶解液容器の連通口側に設けられた該連通口を内包し
た筒状の支持部材と、該筒状支持部材内で軸方向にスラ
イド自在に移動しうる連通手段および少なくとも2の薬
剤容器とからなる輸液容器であって、薬剤容器の口部の
シール部および溶解液容器の連通口のシール部が連通手
段によって連通され、溶解液容器と薬剤容器とが液体連
通するように構成されたことを特徴とする輸液容器であ
る。また、本発明は前記輸液容器において、連通手段が
上下両端に穿刺部を有する両頭針である輸液容器であ
る。更に、本発明は前記輸液容器において、両頭針の下
部穿刺部が溶解液容器の連通口に形成された穿刺針ガイ
ドに挿着されるように配置され、薬剤容器を両頭針側に
押したときに、薬剤容器の口部のシ−ル部および溶解液
容器の連通口のシール部が両頭針によって刺通され、溶
解液容器と薬剤容器とが液体連通するように構成された
輸液容器である。[Means for Solving the Problems] That is, the present invention relates to a solution container made of a plastic material which can be deformed by pressing and which has a drug solution outlet and a communication port for at least two drug containers at both ends.
A tubular support member provided on the communication port side of the dissolution liquid container and including the communication port, a communication means that is slidably movable in the axial direction in the tubular support member, and at least two drug containers. The infusion container consisting of, the seal part of the mouth part of the drug container and the seal part of the communication port of the dissolution liquid container are connected by the communication means, and the dissolution liquid container and the drug container are configured to be in liquid communication Is an infusion container. Further, the present invention is the above-mentioned infusion container, wherein the communicating means is a double-ended needle having puncture portions at both upper and lower ends. Furthermore, the present invention is, in the infusion container, arranged so that the lower puncture part of the double-ended needle is inserted into a puncture needle guide formed at the communication port of the dissolution liquid container, and when the drug container is pushed toward the double-ended needle side. In addition, the seal part of the mouth part of the drug container and the seal part of the communication port of the solution container are pierced by a double-ended needle, and the solution container and the drug container are in fluid communication with each other. ..
【0006】更にまた、本発明は前記輸液容器におい
て、筒状支持部材の開放端を密封するためのキャップが
設けられてなる輸液容器である。また、本発明は前記輸
液容器において、キャップを回転させることによって薬
剤容器が下方移動し、連通手段によって薬剤容器と溶解
液容器とが液体連通する輸液容器である。更に、本発明
は前記輸液容器において、筒状支持部材の上端に設けら
れた押圧部が押圧されることによって、薬剤容器が下方
移動し、連通手段によって薬剤容器と溶解液容器とが液
体連通する輸液容器である。更にまた、本発明は前記輸
液容器において、輸液容器を吊下げるための吊下げ手段
が設けられてなる輸液容器である。また、本発明は前記
輸液容器において、少なくとも2の筒状支持部材を内包
する筒状包囲部材が設けられてなる輸液容器である。更
に、本発明は前記輸液容器において、溶解液容器の薬液
取出口に輸液容器を自立させるためのスタンドを設けて
なる輸液容器である。Furthermore, the present invention is the infusion container, wherein the infusion container is provided with a cap for sealing the open end of the tubular support member. Further, the present invention is the above-mentioned infusion container, wherein the drug container is moved downward by rotating the cap, and the drug container and the solution container are in fluid communication by the communication means. Further, according to the present invention, in the infusion solution container, a pressing portion provided at an upper end of the cylindrical support member is pressed to move the medicine container downward, and the medicine container and the dissolution liquid container are in liquid communication by the communication means. It is an infusion container. Furthermore, the present invention is the infusion container, wherein the infusion container is provided with hanging means for suspending the infusion container. Further, the present invention is the infusion container, wherein the infusion container is provided with a tubular enclosing member that encloses at least two tubular support members. Furthermore, the present invention is the above-mentioned infusion container, wherein a stand for making the infusion container self-support is provided at the drug solution outlet of the dissolution liquid container.
【0007】[0007]
【作用】上記の構成によれば、一つの薬剤容器を溶解液
容器側に押すと、連通手段、たとえば両頭針の上部穿刺
部が薬剤容器の口部のシール部、下部穿刺部が溶解液容
器の連通口のシール部を刺通するので両容器は連通する
ことができる。両容器連通後は、輸液容器を反転させて
溶解液容器が上になるようにし、溶解液容器を手で揉む
ように押圧して溶解液容器内の溶解液を薬剤容器側に移
行させれば、薬剤容器内の乾燥薬剤を溶解液と混合する
ことができる。また、薬剤を溶解液と混合させた後は、
更に輸液容器を反転させて溶解液容器が下になるように
し、薬剤容器内に存する薬剤と混合された溶解液を溶解
液容器側に移行させる。一方、他方の薬剤容器は一つの
薬剤容器の薬剤と溶解液の混合が完全に終わってから、
他方の薬剤容器と既に一つの薬剤容器中の薬剤を溶解し
た混合溶液を収容した溶解液容器とを同様に両頭針によ
って連通するか、あるいは一つの薬剤容器と溶解液容器
とを連通するとほぼ同時に他方の薬剤容器と溶解液容器
とを連通させて二つの薬剤と一つの溶解液とを混合する
か、あるいはまた輸液容器を反転させながら一つの薬剤
と溶解液とを混合している途中で他方の薬剤容器と溶解
液容器とを連通させて、所望の薬液を調製したりするこ
とができる。According to the above construction, when one drug container is pushed toward the solution container, the communication means, for example, the upper puncture part of the double-ended needle is the seal part at the mouth of the drug container, and the lower puncture part is the solution container. Since the seal portion of the communication port is pierced, both containers can communicate with each other. After communicating both containers, invert the infusion container so that the dissolution liquid container is on the top, press the dissolution liquid container by rubbing it by hand to move the dissolution liquid in the dissolution liquid container to the drug container side, The dry drug in the drug container can be mixed with the lysate. Also, after mixing the drug with the lysate,
Further, the infusion container is turned over so that the dissolution liquid container faces downward, and the dissolution liquid mixed with the drug existing in the drug container is transferred to the dissolution liquid container side. On the other hand, in the other drug container, after the mixing of the drug in one drug container and the solution is completed,
Similarly, the other drug container and the dissolution liquid container containing the mixed solution in which the drug in one drug container is already dissolved are communicated with each other by a double-ended needle, or when one drug container and the dissolution liquid container are communicated with each other, almost at the same time. The other drug container and the dissolution liquid container are communicated with each other to mix the two drugs and one dissolution liquid, or the other in the middle of mixing the one drug and the dissolution liquid while reversing the infusion container. The desired drug solution can be prepared by connecting the drug container and the solution container to each other.
【0008】[0008]
【実施例】本発明輸液容器の一例を実施例にて説明す
る。図1は本発明輸液容器の一例を示す要部断面図、図
2は図1の斜視図、図3は図1の輸液容器のキャップと
カプセルとの断面図、図4は本発明輸液容器の他の実施
例を示す要部断面図、図5は図4のX−X線断面図、図
6は溶解液容器の薬液取出口付近の他の実施例を示す説
明図、図7は図6のスタンドの要部断面図である。図中
1および31は薬剤容器、2および32は溶解液容器、3お
よび33は両頭針、4および34は筒状の支持部材、5はキ
ャップ、6および43は薬剤容器の連通口、7および45は
薬液取出口、8および44は溶解液容器の連通口、9、1
0、43および50はゴム栓を示す。EXAMPLES An example of the infusion container of the present invention will be described with reference to Examples. FIG. 1 is a sectional view of an essential part showing an example of the infusion container of the present invention, FIG. 2 is a perspective view of FIG. 1, FIG. 3 is a sectional view of a cap and a capsule of the infusion container of FIG. 1, and FIG. FIG. 5 is a cross-sectional view of a main part showing another embodiment, FIG. 5 is a cross-sectional view taken along line XX of FIG. 4, FIG. 6 is an explanatory view showing another embodiment near the chemical solution outlet of the dissolution liquid container, and FIG. FIG. 3 is a cross-sectional view of essential parts of the stand. In the figure, 1 and 31 are drug containers, 2 and 32 are solution containers, 3 and 33 are double-ended needles, 4 and 34 are cylindrical support members, 5 is a cap, 6 and 43 are communication ports for drug containers, 7 and 45 is a chemical solution outlet, 8 and 44 are communication ports of a solution container, 9 and 1
0, 43 and 50 indicate rubber stoppers.
【0009】図1は本発明輸液容器の一例を示す要部断
面図で2個の薬剤容器1、1, および連通手段である両
頭針3、3, が夫々筒状の支持部材であるカプセル4、
4,およびキャップ5、5, によって密閉された容器に
収容され、1個の溶解液容器2の二つの連通口8および
8, が夫々両頭針3、3, で連通しうるように構成され
ている。カプセル4および4, の底端は溶解液容器2の
連通口8および8, 付近で夫々溶解液容器2と結合され
るとともに、その開放端である上端はキャップ5および
5, で密閉される。カプセル4及び4, の中には両頭針
3および3, とその口部を下向きにした薬剤容器1およ
び1, が軸方向にスライド可能に収容されている。そし
て、キャップ5および5, を回転させると、薬剤容器1
および1, が下降して、両頭針3および3, によって薬
剤容器1および1, のゴム栓9および9, と溶解液容器
2の閉鎖膜18および18, が夫々連通される。そして各薬
剤容器の粉末薬剤と溶解液容器の溶解液が混合される。
図1では薬剤容器が2個の場合の実施例について説明し
ているが、薬剤容器が3個以上の場合についても同様に
構成される。また、図1は左側のキャップ5とカプセル
4から構成された密閉容器と右側のキャップ5, とカプ
セル4, から構成された密閉容器は同じ構成になってい
るが異なった構成でもよい。以下、図1の各器具の構成
を主として左側の薬剤容器1を収納するキャップ5およ
びカプセル4によってなる密閉容器に従って説明する。FIG. 1 is a sectional view of an essential part showing an example of the infusion container of the present invention. Two drug containers 1 , 1 and a double-ended needle 3 , 3 , which is a communication means , are each a capsule 4 which is a cylindrical support member. ,
4, and cap 5, 5 are housed in a sealed container by, one solvent vessel 2 two communication port 8 and 8, but is configured to be communicated in each double-ended needle 3,3, There is. Capsules 4 and 4, the bottom end is solvent container 2 of the communication port 8 and 8, while being combined with each solvent vessel 2 near the upper end thereof is an open end cap 5 and 5, in the closed. Capsule 4 and 4, the drug container 1 and 1 was down double-edged needle 3 and 3, and its mouth is in, but is slidably accommodated in the axial direction. Then, the cap 5 and 5, when the rotation, medicament container 1
And 1, is lowered, double-edged needle 3 and 3, the drug container 1 and 1, the rubber stopper 9 and 9, the solvent vessel 2 closed film 18 and 18, but passed people communicating respectively. Then, the powder drug in each drug container and the solution in the solution container are mixed.
Although FIG. 1 illustrates the embodiment in which the number of drug containers is two, the configuration is also the same when the number of drug containers is three or more. Further, FIG. 1 is a closed container and a right cap 5 constituted from the left side of the cap 5 and the capsule 4, and the capsule 4, a closed container made from may be configured differently but have the same configuration. Hereinafter, the configuration of each device in FIG. 1 will be described mainly in accordance with a closed container including a cap 5 and a capsule 4 that accommodates the drug container 1 on the left side.
【0010】薬剤容器1は一般にガラス製であり、その
連通口6はゴム栓9などの密封部材で密封されており、
ゴム栓9はさらにアルミなどで作られたカバー部材19で
巻締めされ口部に固定されている。薬剤容器1としては
市販の薬剤容器が使用可能であり、カバー部材19はその
天面が取り外され、両頭針3の上部穿刺針11が穿刺され
る位置に透孔が形成される。なお、薬剤容器1内には粉
末製剤や固形製剤、凍結乾燥製剤などの乾燥製剤が収容
されている。The medicine container 1 is generally made of glass, and its communication port 6 is sealed with a sealing member such as a rubber stopper 9.
The rubber stopper 9 is further wound by a cover member 19 made of aluminum or the like and fixed to the mouth portion. A commercially available drug container can be used as the drug container 1, the top surface of the cover member 19 is removed, and a through hole is formed at a position where the upper puncture needle 11 of the double-ended needle 3 is punctured. The drug container 1 contains dry preparations such as powder preparations, solid preparations and freeze-dried preparations.
【0011】キャップ5およびカプセル4は、薬剤容器
1を図1に示すように収容してこれを保持するととも
に、薬剤容器1を下方に移動させるための補助具として
機能するものであり、通常ポリエチレンやポリプロピレ
ン、ポリエステル、ポリ塩化ビニル、ポリカーボネー
ト、ABS樹脂などの合成樹脂で形成されている。キャ
ップ5は図3に示すように、カプセル4の開放端を密封
するとともに、薬剤容器1を下方に移動させる機能を有
している。キャップ5の側壁の下端には、キャップ5と
カプセル4の間を気密にシールする係合突起21が形成さ
れ、カプセル4の内壁の係合溝22と係合するように形成
されている。螺旋溝23はカプセル4の内壁を係合溝22か
ら螺旋状に縦走して設けられており、これとキャップ3
の係合突起21とで薬剤容器押下手段が構成されている。
図示していないが螺旋溝23の代わりに螺旋状に斜走する
突条を採用してもよく、この場合、キャップ5の係合突
起21は突条の下に接触するように配置される。The cap 5 and the capsule 4 receive the drug container 1 as shown in FIG. 1 and hold it, and also function as an auxiliary tool for moving the drug container 1 downward. It is made of synthetic resin such as polypropylene, polyester, polyvinyl chloride, polycarbonate, and ABS resin. As shown in FIG. 3, the cap 5 has a function of sealing the open end of the capsule 4 and moving the drug container 1 downward. An engagement protrusion 21 is formed at the lower end of the side wall of the cap 5 to hermetically seal between the cap 5 and the capsule 4, and is formed so as to engage with an engagement groove 22 on the inner wall of the capsule 4. The spiral groove 23 is provided by vertically extending the inner wall of the capsule 4 from the engagement groove 22 in a spiral shape.
And the engaging projections 21 form a medicine container pressing means.
Although not shown, a spirally slanting projection may be employed instead of the spiral groove 23, and in this case, the engaging projection 21 of the cap 5 is arranged so as to contact under the projection.
【0012】この薬剤容器1を挿着したキャップ5は、
図3に示すようにその天面が閉鎖端で他面が開放端から
なり、開放端の下端に設けられた係合突起21によってカ
プセル4の開放端の上端の内壁に設けられた係合溝22と
係合するようになっている。キャップ5の外壁の中間に
は突起24が設けられ、突起24がカプセル4の上端25の位
置まで下方移動したときにキャップ5の下方移動が止ま
るようになっている。カプセル4は図1に示すように薬
剤容器1の一部と両頭針3とを収容しており、上部は開
放端、下部は溶解液容器2の連通口8付近の外壁と結合
した結合端からなる筒状の容器である。カプセル4の内
壁の中間には薬剤容器1が下方に脱落しないように押さ
える環状突起、数本の脚部等からなる支え部材20が形成
されている。The cap 5 having the medicine container 1 inserted therein is
As shown in FIG. 3, its top surface is a closed end and the other surface is an open end, and an engaging groove provided on the inner wall of the upper end of the capsule 4 by an engaging projection 21 provided on the lower end of the open end. It is designed to engage with 22. A protrusion 24 is provided in the middle of the outer wall of the cap 5, and the downward movement of the cap 5 is stopped when the protrusion 24 moves downward to the position of the upper end 25 of the capsule 4. As shown in FIG. 1, the capsule 4 accommodates a part of the drug container 1 and the double-ended needle 3, the upper part is an open end, and the lower part is a connecting end connected to an outer wall near the communication port 8 of the dissolution liquid container 2. It is a cylindrical container. In the middle of the inner wall of the capsule 4, there is formed a support member 20 including an annular projection that holds the drug container 1 downward so as not to drop out, and several legs.
【0013】カプセル4の中に溶解液容器2と薬剤容器
1の間に挟まれるように両頭針3が挿着されている。両
頭針3の構成を図1の右側のキャップ5, とカプセル4
, からなる密閉容器内にある両頭針3, について説明す
ると、両頭針3, は溶解液容器2の連通口8, のシ−ル
部18, を刺通する下部穿刺部12, と薬剤容器1の口部の
連通口6のゴム栓9を刺通する上部穿刺部11, およびこ
れらの中間に設けられたハブ14, からなっており、ハブ
14, の外周でカプセル4, の内壁と係合している。上部
穿刺部11, には刃先を保護するとともに先に溶解液容器
2の連通口8,が刺通されたときに溶解液のリークが起
こらないようにゴムキャップを被せておいてもよい。ハ
ブ14, には、カプセル4, の内壁との係合を良くし、両
頭針3,がぶれたりせずに正確に連通口8のシ−ル部18
, に導かれるように、上方または下方に突出する環状の
係合腕27, が設けられている。係合腕27, はカプセル4
の両頭針係合溝(図示せず)と係合して下降移動すると
ともに、その先端に設けられた突出部がカプセル内壁に
設けられた両頭針係合溝の段部(図示せず)と係合して
両頭針3にかかる荷重が所定の大きさにならないと係合
腕27, が段部から外れないようになっている。両頭針3
は通常ポリプロピレン、ABS樹脂、ポリカ−ポネ−ト
などの合成樹脂や金属で形成されるが、使用後の廃棄を
考慮した場合、合成樹脂で形成するのが好ましい。ま
た、両頭針3の中空部分は薬液の通路の他に容器内の空
気をリ−クするための通路を形成してもよい。A double-ended needle 3 is inserted in the capsule 4 so as to be sandwiched between the solution container 2 and the drug container 1. Right cap 5 in FIG. 1 the structure of the double-edged needle 3, the capsule 4
When sealed in a container double-edged needle 3 will be described consisting of double-ended needle 3, the dissolving liquid communication port 8 of the container 2, the sheet - lower puncture part 12 pierces the pole tip 18, a medicament container 1 the upper puncture 11 pierce the rubber stopper 9 of the hole 6 of the mouth hub 14 and provided in the four intermediate, has become the hub
14, the capsule 4 at the outer periphery of, and engages the inner wall of the. Upper puncture 11, may be previously covered with a rubber cap as leak solution does not occur when the communication port 8 of the solvent vessel 2 above, were pierced to protect the cutting edge on. Hub 14, the is to improve the engagement between the capsule 4, the inner wall, precisely of the communication port 8 without or double-ended needle 3, is blurred sheet - le 18
, As directed to the annular engaging arms 27 protruding upward or downward, it is provided. Engaging arm 27 , is capsule 4
While engaging with a double-ended needle engaging groove (not shown) of the double-ended needle engaging groove (not shown), a protrusion provided at the tip of the double-ended needle engaging groove (not shown) is provided on the inner wall of the capsule. When the load applied to the double-edged needle 3 engages is not a predetermined size engaging arm 27, but so as not disengaged from the stepped portion. Double-ended needle 3
Is usually formed of a synthetic resin such as polypropylene, ABS resin, or polycarbonate, or a metal, but in consideration of disposal after use, it is preferably formed of a synthetic resin. Further, the hollow portion of the double-ended needle 3 may form a passage for leaking the air in the container in addition to the passage for the liquid medicine.
【0014】シ−ル部18, は天面に下部穿刺針12, の直
径よりも小さな透孔を有するキャップ状の部材であり、
図1に示すように連通口8, の中間に装着される。ま
た、溶解液容器2とカプセル4, の下端の結合は溶解液
容器2の連通口8, を構成する外壁の嵌合突起17, とカ
プセル4, の下端の内壁の嵌合溝29, とが嵌合され、溶
解液容器2の外壁とカプセル4の外壁が溶着または接着
剤で接着されたりなどして形成される。上部穿刺針11,
は確実に先に薬剤容器1のゴム栓9が刺通されるように
下部穿刺針12, より鋭利に形成されている。図1では上
部穿刺針11, が中央部分の尖った刃先に形成され、下部
穿刺針12, がベベル状の刃先に形成されているが、刃先
の形状は特に限定されない。[0014] Shi - le unit 18, is a cap-shaped member having a smaller hole than the lower needle 12, the diameter of the top surface,
Communicating port 8 as shown in FIG. 1, it is mounted in the middle. Also, solvent container 2 and the capsule 4, the communicating port 8 of the coupling at the lower end is solvent container 2, to constitute the outer wall of the fitting protrusion 17, the capsule 4, the lower end of the inner wall of the fitting groove 29, capital is The outer wall of the solution container 2 and the outer wall of the capsule 4 are fitted together and are formed by welding or adhering with an adhesive. Upper puncture needle 11 ,
The lower needle 12 as the rubber stopper 9 of the drug container 1 is pierced reliably previously, are more sharp form. Upper needle 11 in FIG. 1, but are formed on the sharpened edge of the central portion, the lower needle 12, are formed over a substrate beveled cutting edge, the cutting edge of the shape is not particularly limited.
【0015】溶解液容器2は一般にポリエチレンやポリ
プロピレン、ポリエステルなどの比較的柔らかい合成樹
脂で形成された押圧変形しうる容器であり、その上端に
溶解液容器2側の連通口8と8, 、下端に薬液取出口7
を有している。連通口8は両頭針3を介して薬剤容器1
と連通するための口部であり、図1に示すように、その
先端は下部穿刺針12, を挿着するためのパイプ状の穿刺
針ガイド28に形成されており、この穿刺針ガイド28の中
間に相当する位置に溶解液容器2を密封する閉鎖膜18が
形成されている。そして、連通口8, の上端外壁にはカ
プセル4, の嵌合溝29, に嵌入するための嵌合突起17,
が形成されている。なお、溶解液容器2内には生理食塩
水、ブドウ糖液、蒸留水、電解質液などの溶解液が収容
されている。また、溶解液容器2の連通口8は、図1に
示すような閉鎖膜を有する穿刺針ガイド28の形状に限定
するものではなく、薬液取出口7と同様の閉鎖膜をゴム
栓と押さえ部材からなる密封部材で被った通常のボトル
の場合と同様の形状にしてもよい。The dissolution liquid container 2 is a container which is generally made of a relatively soft synthetic resin such as polyethylene, polypropylene or polyester and which can be deformed by pressing. The upper end of the dissolution liquid container 2 is the communication ports 8 and 8 on the dissolution liquid container 2 side and the lower end. The chemical solution outlet 7
have. The communication port 8 is connected to the drug container 1 via the double-ended needle 3.
As shown in FIG. 1, the mouth portion for communicating with the puncture needle guide 28 has a pipe-shaped puncture needle guide 28 for inserting the lower puncture needle 12 , . A closing film 18 for sealing the dissolution liquid container 2 is formed at a position corresponding to the middle. Then, the communicating port 8, the capsule 4 is on the upper end outer wall of the fitting groove 29 fitting projections 17 to fit into,
Are formed. The dissolution liquid container 2 contains a dissolution liquid such as physiological saline, glucose solution, distilled water, and electrolyte solution. Further, the communication port 8 of the dissolution liquid container 2 is not limited to the shape of the puncture needle guide 28 having a closing film as shown in FIG. 1, but the same closing film as the drug solution outlet 7 is provided with a rubber stopper and a pressing member. The shape may be the same as that of a normal bottle covered with a sealing member made of.
【0016】薬液取出口7は通常のボトルの場合と同様
の構成をしており、例えば、図1は閉鎖膜26の上に押さ
え部材15とこれに装着されたゴム栓10からなる密封部材
を被せた構成である。密封部材であるゴム栓10の溶解液
容器2への取り付けは、薬液取出口7の外壁に形成され
たフランジと押さえ部材15との溶着により行われる。な
お、密封部材のゴム栓10はその表面が汚染されないよう
にフィルムなどのカバー部材で保護されていてもよい。
本発明の輸液用容器は、溶解液容器2にカプセル4を気
密に取り付け、カプセル4の中に両頭針3と薬剤容器1
の口部側をセットし、カプセル4の開放端にキャップ5
を気密に取り付ければ完成する。カプセル4の下端にあ
る溶解液容器2との連通口8には、両頭針3の下部穿刺
針12を挿着する穿刺針ガイド28が設けられているが、下
部穿刺針12をシ−ルするシール部材を装着してもよい。
なお、符号13は溶解液容器2の吊下孔で、ハンガ−に懸
架して薬剤と溶解液との混合をしたり、薬液取出口7に
輸液セットを取りつけて点滴操作をしたりする。また、
図1では2つのカプセル4および4, は溶解液容器2の
連通口8および8, 付近で結合しているが、薬剤と溶解
液との混合の際に筒状支持部材であるカプセル4および
4, が不安定であるならば、2つのカプセル4および4
, が溶解液容器2の上部の中心部から吊下孔13の方向へ
延びている支柱60と固定されるために、これらを内包す
る筒状包囲部材が設けられてもよい。The drug solution outlet 7 has the same structure as in the case of a normal bottle. For example, in FIG. 1, a sealing member consisting of a pressing member 15 and a rubber stopper 10 attached to the pressing member 15 is provided on the closure membrane 26. It is a covered structure. The rubber stopper 10, which is a sealing member, is attached to the solution container 2 by welding the flange formed on the outer wall of the drug solution outlet 7 and the pressing member 15. The rubber stopper 10 of the sealing member may be protected by a cover member such as a film so that the surface thereof is not contaminated.
In the infusion container of the present invention, the capsule 4 is airtightly attached to the dissolution liquid container 2, and the double-ended needle 3 and the drug container 1 are placed in the capsule 4.
Set the mouth side of the cap and put the cap 5 on the open end of the capsule 4.
It is completed if it is attached airtightly. A puncture needle guide 28, into which the lower puncture needle 12 of the double-ended needle 3 is inserted, is provided at the communication port 8 at the lower end of the capsule 4 with the dissolution liquid container 2, and the lower puncture needle 12 is sealed. A seal member may be attached.
Reference numeral 13 is a suspension hole of the solution container 2, which is suspended on a hanger to mix the drug and the solution, or an infusion set is attached to the drug solution outlet 7 for drip operation. Also,
Figure 1, 2 capsules 4 and 4, the communicating port 8 and 8 of the solvent vessel 2, although attached in the vicinity of the capsule 4 and 4 is a cylindrical support member upon mixing of the drug and the solution If is unstable, then two capsules 4 and 4
Since, is fixed to the support column 60 extending from the central portion of the upper portion of the dissolution liquid container 2 toward the suspension hole 13, a cylindrical surrounding member that encloses the support column 60 may be provided.
【0017】次に、本発明の輸液用容器の使用について
詳しく説明する。キャップ5を時計方向に回すと、キャ
ップ5の係合突起21がカプセル4の係合溝22に嵌入され
ているため、その内部に保持された薬剤容器1とともに
螺旋溝23に沿って下方に移動する。そして、薬剤容器1
の口部のゴム栓9が両頭針3の上部穿刺針11で刺通さ
れ、口部が両頭針3のハブ14に達すると、両頭針3にか
かる荷重が大きくなるので、両頭針3の係合腕27が両頭
針係合溝から外れ、両頭針3は薬剤容器1とともに更に
下方に移動し、両頭針3の下部穿刺針12が溶解液容器2
の連通口28のシ−ル部18に刺通される。こうして薬剤容
器1と溶解液容器2が両頭針3を介して連通されたら、
次に、溶解液容器2を上にしてこれを押圧すると、溶解
液容器2内の溶解液が薬剤容器1内に流入し、薬剤容器
1内の乾燥製剤と混合して薬液となる。次いで、図1の
右側のキャップ5, およびカプセル4,内に収容された
薬剤容器1, と溶解液容器2との連通口8, での連通に
ついても同様な操作で溶解液容器2内の溶解液と薬剤容
器1, 内の乾燥製剤との混合が行われる。次に、キャッ
プ5を上にして、吊下孔13をハンガー(図示していな
い)などに架け、ポンピングにより溶解液容器2内に薬
剤容器1内の薬液を戻し、薬液取出口7に輸液セットな
どを結合すれば輸液治療を行うことができる。なお、カ
プセル4と溶解液容器2を取外し可能にしてもよい。Next, the use of the infusion container of the present invention will be described in detail. When the cap 5 is rotated clockwise, the engaging projection 21 of the cap 5 is fitted into the engaging groove 22 of the capsule 4, and thus moves downward along the spiral groove 23 together with the drug container 1 held therein. To do. And the drug container 1
When the rubber plug 9 of the mouth portion of the double-ended needle 3 is pierced by the upper puncture needle 11 of the double-ended needle 3 and the mouth portion reaches the hub 14 of the double-ended needle 3, the load applied to the double-ended needle 3 becomes large. The joint arm 27 disengages from the double-ended needle engaging groove, the double-ended needle 3 moves further downward together with the drug container 1, and the lower puncture needle 12 of the double-ended needle 3 causes the solution container 2 to move.
Is pierced by the seal portion 18 of the communication port 28. In this way, when the drug container 1 and the solution container 2 are communicated with each other via the double-ended needle 3,
Next, when the dissolution liquid container 2 is turned up and pressed, the dissolution liquid in the dissolution liquid container 2 flows into the medicine container 1 and is mixed with the dry preparation in the medicine container 1 to form a medicine liquid. Then, dissolution of the dissolution liquid in the container 2 by the same operation also for communicating with the communication port 8, of the right cap 5 in FIG. 1, and capsule 4, the drug container 1 housed within, and solvent vessel 2 liquid and drug container 1, mixing with the dry formulation of the inner is performed. Next, with the cap 5 facing upwards, the suspension hole 13 is hung on a hanger (not shown) or the like, the drug solution in the drug container 1 is returned to the solution container 2 by pumping, and the infusion set is set in the drug solution outlet 7. Infusion therapy can be performed by combining such items. The capsule 4 and the solution container 2 may be removable.
【0018】図4は本発明の他の実施例の要部断面図を
示すもので2個の薬剤容器31、31,および両頭針33、33
, が隔壁30によって2室に区画された筒状の支持部材で
あるカプセル34の各室35、35, に夫々収容され、1個の
溶解液容器32の2つの連通口36および36, で夫々連通し
うるように構成されている。カプセル34の底端は環状の
突起39からなっており、溶解液容器32の肩部に設けられ
たアンダ−カット37および37, と結合され密閉室35およ
び35, が形成される。また、カプセル34内を区隔する隔
壁30の底端も突起40からなっており、溶解液容器32の両
連通口36と36,との間の肩部に設けられた凹状溝38に係
合されてカプセル34の支柱になっている。そして、その
上端のカプセル34の外壁には吊下孔41が設けられ、輸液
容器がハンガ−等に懸架されるようになっている。FIG. 4 is a cross-sectional view of the essential parts of another embodiment of the present invention. Two drug containers 31 , 31 and double-ended needles 33, 33 are shown.
, But each chamber 35, 35 of the capsule 34 is a tubular support member which is partitioned into two chambers by a partition wall 30, are respectively housed in two communication ports 36 and 36 of a single solvent vessel 32 in each, s It is configured to communicate with each other. The bottom end of the capsule 34 is composed of annular projection 39, lysates undershoot provided on the shoulder portion of the container 32 - Cut 37 and 37, coupled with the closed chamber 35 and 35, are formed. Further, the bottom end of the partition wall 30 which separates the inside of the capsule 34 is also composed of the projection 40 , and engages with the concave groove 38 provided in the shoulder portion between both the communication ports 36 of the dissolution liquid container 32. It is a pillar of the capsule 34. A suspension hole 41 is provided on the outer wall of the capsule 34 at the upper end thereof so that the infusion container can be suspended on a hanger or the like.
【0019】カプセル34の中には両頭針33および33, と
その口部を下向きにした薬剤容器31および31, が下方向
スライド可能に収容されている。薬剤容器31および31,
の底部はカプセル34の上部内壁と接しており、カプセル
34の上壁には、薬剤容器31および31, を下方向に移動さ
せるための押圧部42および42, が図5に示すように夫々
薬剤容器31および31, の底部の中心付近が接する位置に
設けられている。押圧部42および42, は一般に円形でゴ
ム状弾性体シ−ト、数個の同心襞が重なったもの等から
なっている。この押圧部42および42, を人手で押すこと
によって、薬剤容器31および31, が下降し、両頭針33お
よび33, によって薬剤容器31および31,のゴム栓43およ
び43, 並びに溶解液容器42のシ−ル部48および48, が夫
々連通し、両薬剤容器31と31, の粉末薬剤と溶解液容器
32の溶解液が混合される。The drug container 31 and 31 and double-ended needle 33 and 33, and the mouth portion downward in a capsule 34, but are downwardly slidably received. Drug containers 31 and 31 ,
The bottom of the capsule contacts the upper inner wall of the capsule 34,
The upper wall 34, the drug container 31 and 31, the pressing portion 42 and 42 for moving downward, but in a position respectively drug container 31 and 31, is near the center of the bottom of the contact as shown in FIG. 5 It is provided. Pressing portions 42 and 42, the rubber-like elastic body sheet is generally circular - bets, consist such that overlapping several concentric folds. By pressing the pressing portion 42 and 42, a manually, the drug container 31 and 31, is lowered and double ended needle 33 and 33, the drug container 31 and 31, the rubber plug 43 and 43, as well as the solvent container 42 sheet - le 48 and 48, but through people communicating respectively, solvent container with both drugs vessel 31 31, and the powdered medicine
32 lysates are mixed.
【0020】以下各部分について主として図4の輸液容
器の左側の密閉室35を中心にして説明する。溶解液容器
32は通常ポリエチレンやポリプロピレンなどの合成樹脂
からなり、ボトル状に形成され、内部に蒸留水や生理食
塩水、電解質液、ブドウ糖液などの溶解液が充填されて
おり、その上部に薬剤容器31と液体連通するための連通
口44を有し、その下部に薬液取出口45を有している。連
通口44はパイプ状に形成されている。両頭針33, の下部
穿刺部47, によって刺通されて開通される薄膜からなる
シール部48, でシールされるとともに、シール部48, か
ら連通口44, の開口端までの中空部分は、下部穿刺部47
, をシール部48, まで導く穿刺針ガイド36, からなって
いる。この穿刺針ガイド49, には下部穿刺部47, の一部
が挿着されている。連通口44, には、下部穿刺部47, と
連通口44, の間を液密にシールするシール部材を被せて
おいてもよい。薬液取出口45は一般に通常の輸液容器と
同様に内部にゴム栓50を備えた栓体で密封されており、
図1の薬液取出口7と同様な構成である。The respective parts will be described below mainly focusing on the left closed chamber 35 of the infusion container in FIG. Solution container
32 is usually made of a synthetic resin such as polyethylene or polypropylene, and is formed into a bottle shape, and the inside thereof is filled with a solution such as distilled water, physiological saline, an electrolyte solution, or a glucose solution, and a drug container 31 and It has a communication port 44 for communicating with a liquid, and has a chemical liquid outlet 45 at its lower part. The communication port 44 is formed in a pipe shape. Double-ended needle 33, the sealing portion 48 made of a thin film to be opened is pierced by the bottom piercing portion 47, of, in conjunction with the sealed hollow portion of the seal portion 48 from, to the open end of the communication port 44, the lower Puncture part 47
Consists of the puncture needle guide 36, guided to the sealing portion 48, a. The puncture needle guide 49, lower puncture 47, a part of which is inserted in the. Communication port 44, the may be previously covered with a sealing member for sealing a lower puncture 47, the communication port 44, between the liquid-tight. The drug solution outlet port 45 is generally sealed with a stopper having a rubber stopper 50 inside like a normal infusion container,
The configuration is similar to that of the chemical liquid outlet 7 of FIG.
【0021】溶解液容器32の連通口44側にはカプセル34
が連通口44と同心状に立設されており、溶解液容器32の
肩部にはカプセル34を溶着して固定するか、あるいは図
4に示すようなアンダーカット37がカプセル34の環状の
突起39と係合してカプセル34と溶解液容器32が結合され
る。カプセル34の密閉室35は、その内部に両頭針33と薬
剤容器31とが挿着されており、両頭針33や薬剤容器31を
収容してこれらが輸送中などに移動せず、手で押した時
に容易に移動可能なように、ポリ塩化ビニル、ポリエチ
レン、ポリプロピレン、ABS樹脂、ポリカーボネート
などの樹脂から形成される。その内径が両頭針33のハブ
51の外径や薬剤容器31の外径と同径または僅かに小さく
なるように形成される。なお、カプセル34の内壁に、そ
の中に収容された薬剤容器31の肩より僅か下方位置に、
小さな環状リブ(図示していない)を設けて薬剤容器31
が両頭針33側に容易に移動しないようにしてもよい。ま
た薬剤容器31を押したときに容易に薬剤容器31を移動さ
せることができるように、カプセル34の溶解液容器32側
の端部から両頭針33の挿着位置にかけて縦方向のスリッ
ト(図示していない)を設けてもよい。A capsule 34 is provided on the side of the communication port 44 of the dissolution liquid container 32.
Is erected concentrically with the communication port 44, and the capsule 34 is welded and fixed to the shoulder portion of the dissolution liquid container 32, or an undercut 37 as shown in FIG. By engaging with 39, the capsule 34 and the solution container 32 are combined. The closed chamber 35 of the capsule 34 has a double-ended needle 33 and a drug container 31 inserted therein, and the double-ended needle 33 and the drug container 31 are housed so that they do not move during transportation and are pushed by hand. It is made of a resin such as polyvinyl chloride, polyethylene, polypropylene, ABS resin, or polycarbonate so that it can be easily moved when it is pressed. A hub whose inner diameter is a double-ended needle 33
The outer diameter of 51 and the outer diameter of the drug container 31 are the same or slightly smaller. Incidentally, on the inner wall of the capsule 34, at a position slightly lower than the shoulder of the drug container 31 contained therein,
Drug container 31 with small annular ribs (not shown)
May not be easily moved to the double-ended needle 33 side. Further, in order to easily move the drug container 31 when the drug container 31 is pushed, a slit in the vertical direction from the end of the capsule 34 on the dissolution liquid container 32 side to the insertion position of the double-ended needle 33 (illustrated Not) may be provided.
【0022】カプセル34の中に溶解液容器32と薬剤容器
31, の間に挟まれるように挿着される両頭針33, は、連
通口44, を刺通する下部穿刺部47, と薬剤容器31, の口
のシール部43, (通常ゴム栓でシールされている)を刺
通する上部穿刺部46, 、およびこれらの中間に設けられ
たハブ51, からなっており、ハブ51, の外周はカプセル
34, の内壁と係合している。上部穿刺部46, には刃先を
保護するとともに先に溶解液容器32の連通口44, が刺通
されたときに溶解液のリークが起こらないようにゴムキ
ャップを被せておいてもよい。ハブ51, には、カプセル
34との係合を良くし、両頭針33, がぶれたりせずに正確
に連通口44, のシール部48, に導かれるように、上方に
突出する環状の係合腕52, を設けてもよい。両頭針33は
通常ポリプロピレン、ABS樹脂などの合成樹脂や金属
で形成されるが、使用後の廃棄を考慮した場合、合成樹
脂で形成するのが好ましく、両頭針33の中空部分として
薬液の通路の他に空気の通路を形成してもよい。図1お
よび図4の輸液容器の連通手段はいずれも両頭針が使用
されているが、連通手段としては他に特表昭61−50
1129号公報に記載の上部が穿刺針で下部が溶解液容
器の中に端部が挿入された一部密閉された中空棒からな
り、中空棒の密閉箇所を折って溶解液容器と連通させ
る、いわゆる折れ棒等を使用してもよい。Dissolution container 32 and drug container in capsule 34
31, double ended needle 33 is inserted so as to be interposed between, is lower puncture 47 pierces the communicating opening 44, a medicament container 31, the mouth of the seal portion 43, the seal (usually rubber stopper upper stick portion 46 to pierce a and have) been, and has become the hub 51, provided in the four intermediate hub 51, the outer periphery of the capsule
34, and engages the inner wall of the. Upper puncture 46, may be previously covered with a rubber cap as leak solution does not occur when the communication port 44 of the solvent container 32 above, were pierced to protect the cutting edge on. Hub 51 , with a capsule
To improve the engagement with 34, double-ended needle 33, as guided accurately communicating port 44, the seal portion 48, to without the or blur, annular engaging arms 52 projecting upward, the provided Good. The double-ended needle 33 is usually formed of a synthetic resin such as polypropylene or ABS resin, or a metal, but in consideration of disposal after use, it is preferably formed of a synthetic resin, and the hollow portion of the double-ended needle 33 serves as a passage for a chemical solution. Alternatively, an air passage may be formed. A double-headed needle is used for the communication means of the infusion solution container shown in FIGS. 1 and 4, but as a communication means, there is another special table, Sho 61-50.
In 1129, the upper part is composed of a puncture needle and the lower part is composed of a partially sealed hollow rod having an end portion inserted into a dissolution liquid container, and a closed portion of the hollow rod is folded to communicate with the dissolution liquid container. A so-called bent rod or the like may be used.
【0023】次に、この輸液容器の使用について説明す
る。先ず、輸液容器を溶解液容器32が下になるようにし
ておき、押圧部42から手で薬剤容器31を溶解液容器32側
に押すと、薬剤容器31はカプセル34内をスライドして両
頭針33を押し下げ、その結果両頭針33, の上部穿刺部46
, が薬剤容器31, の口部のシール部43, を刺通し同時に
下部穿刺部47, が溶解液容器42の連通口44,のシール部4
8, を刺通する。こうして溶解液容器32と薬剤容器31が
液体連通される。次いで、輸液容器を反転させて溶解液
容器32が上になるようにして、溶解液容器32の胴部を手
で揉むように押して変形させる。その結果溶解液容器32
内の溶解液は薬剤容器31の中に移行し、薬剤容器31内に
収納された乾燥薬剤と混合される。次に、再び輸液容器
を反転させて溶解液容器32が下になるようにして溶解液
容器32を手で揉むように押せば、乾燥薬剤の溶解された
溶解液は溶解液容器32内に戻る。次いで、密閉室35, 内
の薬剤容器31, と溶解液容器32との連通口44, との連通
が前記密閉室35での操作と同様にして行われる。こうし
て薬液が調整された後、輸液容器は、吊下孔41でハンガ
ーなどに架けられ、薬液取出口45に輸液セットなどを接
続して点滴操作が行われる。以上本発明輸液容器の操作
を薬剤容器31と溶解液容器32の連通操作が終了した後
に、薬剤容器31, と溶解液容器32, の連通操作を行うよ
うに説明したが、この操作を同時にしてもよい。Next, the use of this infusion container will be described. First, the infusion solution container 32 is placed with the dissolution solution container 32 facing downward, and when the medicine container 31 is pushed to the dissolution solution container 32 side by hand from the pressing portion 42, the medicine container 31 slides in the capsule 34 and is a double-ended needle. 33 is depressed, resulting in the upper puncture 46 of the double-ended needle 33 ,
, But the drug container 31, the communication port 44 of the sealing portion 43, a lower puncture 47 simultaneously pierces the mouth portion, the solvent container 42, the sealing portion 4 of the
8, the Togedorisuru. In this way, the solution container 32 and the drug container 31 are in fluid communication. Next, the transfusion container is turned over so that the dissolution liquid container 32 is on the upper side, and the body of the dissolution liquid container 32 is pushed by rubbing it by hand to deform it. As a result, the solution container 32
The dissolved liquid therein moves into the drug container 31 and is mixed with the dry drug contained in the drug container 31. Next, the solution container in which the dried drug is dissolved is returned to the inside of the solution container 32 by reversing the infusion solution container and pushing the solution solution container 32 so that the solution solution container 32 faces downward. Then, the sealed chamber 35, communicating the communication port 44, the medicine container 31 of the inner, and the solvent vessel 32 is carried out in the same manner as the operation in the sealed chamber 35. After the drug solution is adjusted in this way, the infusion container is hung on the hanger or the like at the hanging hole 41, and an infusion set or the like is connected to the drug solution outlet 45 to perform the drip operation. Above operation of the present invention the infusion container after communicating operation of the dissolution liquid container 32 and drug container 31 has been completed, the drug container 31, a solvent vessel 32, has been described to perform a communication operation, and this operation at the same time May be.
【0024】図6〜図7は本発明の他の実施例の図面を
示すものであり、例えば図1の輸液容器の薬液取出口7
に輸液用容器を自立させるためのスタンド53を設けた構
成になっている。スタンド53を脚部54と嵌合部55からな
り、嵌合部55の内壁で押さえ部材15の外壁と嵌合してい
る。スタンド53の材質としては限定するものではないが
一般に金属や合成樹脂が使用される。6 to 7 are views showing another embodiment of the present invention. For example, the drug solution outlet 7 of the infusion container of FIG. 1 is shown.
In addition, a stand 53 is provided for self-supporting the infusion container. The stand 53 includes a leg portion 54 and a fitting portion 55, and the inner wall of the fitting portion 55 is fitted to the outer wall of the pressing member 15. The material of the stand 53 is not limited, but generally metal or synthetic resin is used.
【0025】[0025]
【発明の効果】本発明輸液容器を使用することによっ
て、2種以上の乾燥薬剤を1つの薬剤容器に収容できな
い薬剤の組み合わせの混合薬剤や2種以上の乾燥薬剤を
混合して液体に溶解させるより個々の薬剤を順番に液体
に溶解させた方がよい2種以上の薬剤を液体に溶解させ
る際に、操作が容易で手間がかからず、混合された薬液
が漏れる虞がなく、無菌的に薬剤と溶解液を混合するこ
とができる。また本発明輸液容器は部品点数が少なく安
価に製品を提供することができる。EFFECTS OF THE INVENTION By using the infusion container of the present invention, a mixed drug of a combination of drugs that cannot contain two or more dry drugs or one or more dry drugs can be mixed and dissolved in a liquid. It is better to dissolve the individual drugs in the liquid in order. When dissolving two or more drugs in the liquid, the operation is easy and hassle-free, there is no risk of the mixed drug liquid leaking, and it is sterile. The drug and the solution can be mixed with each other. Further, the infusion container of the present invention has a small number of parts and can provide a product at low cost.
【図1】本発明輸液容器の一例を示す要部断面図。FIG. 1 is a sectional view of an essential part showing an example of the infusion solution container of the present invention.
【図2】図1の斜視図。FIG. 2 is a perspective view of FIG.
【図3】図1の輸液容器のキャップとカプセルとの断面
図。FIG. 3 is a cross-sectional view of a cap and a capsule of the infusion container of FIG.
【図4】本発明輸液容器の他の実施例を示す要部断面
図。FIG. 4 is a cross-sectional view of essential parts showing another embodiment of the infusion container of the present invention.
【図5】図4のX−X線断面図。5 is a sectional view taken along line XX of FIG.
【図6】溶解液容器の薬液取出口付近の他の実施例を示
す説明図。FIG. 6 is an explanatory view showing another embodiment in the vicinity of the drug solution outlet of the dissolution liquid container.
【図7】図6のスタンドの要部断面図。7 is a cross-sectional view of a main part of the stand shown in FIG.
1、31 薬剤容器 2、32 溶解液容器 3、33 両頭針 4、34 カプセル 5 キャップ 6、43 薬剤容器の連通口 7、45 薬液取出口 8、44 溶解液容器の連通口 13、41 吊下孔 42 押圧部 1, 31 Drug container 2, 32 Dissolution container 3, 33 Double-ended needle 4, 34 Capsule 5 Cap 6, 43 Communication port for drug container 7, 45 Drug solution outlet 8, 44 Dissolution container communication port 13, 41 Suspension Hole 42 Pressing part
Claims (9)
の連通口とを両端に有する変形しうるプラスチック製の
溶解液容器と、該溶解液容器の連通口側に設けられた該
連通口を内包した筒状支持部材と、該筒状支持部材内で
軸方向にスライド自在に移動しうる連通手段および少な
くとも2の薬剤容器とからなる輸液容器であって、薬剤
容器の口部のシール部および溶解液容器の連通口のシー
ル部が連通手段によって連通され、溶解液容器と薬剤容
器とが液体連通するように構成されたことを特徴とする
輸液容器。1. A deformable plastic solution container having a drug solution outlet and a communication port for at least two drug containers at both ends, and the communication port provided on the communication port side of the solution container. An infusion container comprising a tubular support member contained therein, a communicating means that is slidably movable in the axial direction within the tubular support member, and at least two drug containers, wherein a sealing portion at the mouth of the drug container and An infusion container characterized in that the seal portion of the communication port of the dissolution liquid container is connected by a communication means so that the dissolution liquid container and the drug container are in liquid communication.
頭針である請求項1記載の輸液容器。2. The infusion container according to claim 1, wherein the communication means is a double-ended needle having puncture portions at both upper and lower ends.
口に形成された穿刺針ガイドに挿着されるように配置さ
れ、薬剤容器を両頭針側に押したときに、薬剤容器の口
部のシ−ル部および溶解液容器の連通口のシール部が両
頭針によって刺通され、溶解液容器と薬剤容器が液体連
通するように構成されたことを特徴とする請求項2記載
の輸液容器。3. The lower puncture part of the double-ended needle is arranged so as to be inserted into a puncture needle guide formed at the communication port of the dissolution liquid container, and when the drug container is pushed toward the double-ended needle side, 3. The seal part of the mouth part and the seal part of the communication port of the dissolution liquid container are pierced by a double-ended needle so that the dissolution liquid container and the drug container are in liquid communication with each other. Infusion container.
キャップが設けられてなる請求項1〜3記載の輸液容
器。4. The infusion container according to claim 1, further comprising a cap for sealing the open end of the tubular support member.
容器が下方移動し、連通手段によって薬剤容器と溶解液
容器とが液体連通する請求項4記載の輸液容器。5. The infusion container according to claim 4, wherein the drug container is moved downward by rotating the cap, and the drug container and the solution container are in liquid communication by the communication means.
が押圧されることによって、薬剤容器が下方移動し、連
通手段によって薬剤容器および溶解液容器とが液体連通
する請求項1〜3記載の輸液容器。6. The medicine container moves downward by pressing a pressing portion provided on the upper end of the cylindrical support member, and the medicine container and the solution container are in liquid communication by the communication means. Infusion container described.
設けられてなる請求項1〜6記載の輸液容器。7. The infusion container according to claim 1, further comprising a suspending means for suspending the infusion container.
筒状包囲部材が設けられてなる請求項1〜7記載の輸液
容器。8. The infusion container according to claim 1, further comprising a tubular enclosing member that encloses at least two tubular supporting members.
立させるためのスタンドが設けられてなる請求項1〜8
記載の輸液容器。9. The stand for making the infusion container self-support is provided at the drug solution outlet of the dissolution liquid container.
Infusion container described.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4164121A JPH05329192A (en) | 1992-05-29 | 1992-05-29 | Infusion container |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4164121A JPH05329192A (en) | 1992-05-29 | 1992-05-29 | Infusion container |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH05329192A true JPH05329192A (en) | 1993-12-14 |
Family
ID=15787150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4164121A Pending JPH05329192A (en) | 1992-05-29 | 1992-05-29 | Infusion container |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH05329192A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007046508A1 (en) * | 2005-10-18 | 2007-04-26 | Canon Kabushiki Kaisha | Liquid ejection cartridge and liquid ejection device |
-
1992
- 1992-05-29 JP JP4164121A patent/JPH05329192A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007046508A1 (en) * | 2005-10-18 | 2007-04-26 | Canon Kabushiki Kaisha | Liquid ejection cartridge and liquid ejection device |
| JP2007111114A (en) * | 2005-10-18 | 2007-05-10 | Canon Inc | Liquid ejection device and liquid ejection cartridge used in the ejection device |
| US8146586B2 (en) | 2005-10-18 | 2012-04-03 | Canon Kabushiki Kaisha | Liquid ejection cartridge and liquid ejection device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3146465B2 (en) | Chemical injection device | |
| JP3456019B2 (en) | Liquid introduction needle and aid for dissolving dry preparation using the same | |
| US3788369A (en) | Apparatus for transferring liquid between a container and a flexible bag | |
| US4781679A (en) | Container system with integral second substance storing and dispensing means | |
| JPH08126683A (en) | Infusion container | |
| JPH06239352A (en) | Solution injection set | |
| JPH021277A (en) | infusion container | |
| EP0598918A1 (en) | Medical container | |
| JPH05212090A (en) | Transfusion container | |
| JPH0236261B2 (en) | ||
| AU3300200A (en) | Ampoule containing a liquid for medical purposes | |
| EP0696448B1 (en) | A liquid container for dispensing medical solutions | |
| EP0542295A1 (en) | Drug vessel | |
| JP3514505B2 (en) | Manufacturing method of solution container | |
| JPH08257101A (en) | Solution injection set | |
| JP2551318B2 (en) | Infusion container | |
| JPH0337067A (en) | Transfusion container | |
| JP3345860B2 (en) | Infusion container | |
| JP3289265B2 (en) | Solution-filled syringe for mixing two components | |
| JP3175127B2 (en) | Infusion container | |
| JP3070044B2 (en) | Infusion container with communication means | |
| JP2550858B2 (en) | Infusion container | |
| JPH06125969A (en) | Drug container set | |
| JPS61501552A (en) | A device for preparing injectable drugs | |
| JPH06121820A (en) | Drug container with communication means |